Browsing Tag
US FDA
379 posts
Lupin obtains tentative FDA approval for generic Canagliflozin Tablets
Global pharmaceutical leader, Lupin Limited, announced its significant achievement of receiving tentative approval from the United States Food…
November 24, 2023
Strides Pharma subsidiary receives FDA approval for bowel prep solution
Strides Pharma Science Limited, through its subsidiary Strides Pharma Global Pte. Limited, Singapore, has recently achieved a significant…
November 23, 2023
FDA approves Ryzneuta by Evive Biotech for reducing febrile neutropenia in cancer patients
Evive Biotech, a global biopharmaceutical company and a subsidiary of Yifan Pharmaceutical Co. Ltd., along with New Jersey-based…
November 22, 2023
Lupin gains FDA approval for generic Pitavastatin Tablets, targeting $298m market
Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration…
November 21, 2023
FDA approves AstraZeneca’s Truqap for advanced breast cancer treatment
In a notable development in the field of oncology, the US Food and Drug Administration (FDA) has approved…
November 20, 2023
Takeda gets ADZYNMA FDA approval for cTTP treatment: A new era in rare disease therapy
Takeda has achieved a monumental milestone in rare disease therapy with the U.S. Food and Drug Administration’s approval…
November 11, 2023
Lilly bags Zepbound FDA approval for obesity treatment
The U.S. Food and Drug Administration has granted approval to Eli Lilly’s Zepbound (tirzepatide) injection, making it the…
November 9, 2023
FDA approves Recor Medical’s Paradise Ultrasound RDN System for hypertension treatment
The U.S. Food and Drug Administration (FDA) has granted approval to Recor Medical, Inc. and its parent company,…
November 8, 2023
FDA approves ZITUVIMET by Zydus Lifesciences for Type 2 diabetes treatment
Zydus Lifesciences Limited has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval…
November 6, 2023
FDA approves Novartis’ Cosentyx for hidradenitis suppurativa treatment
Novartis, a global leader in immuno-dermatology and rheumatology, announced the U.S. Food and Drug Administration’s approval of Cosentyx…
November 1, 2023